APP
ELV icon

Alpha Paradigm Partners’s Elevance Health ELV Stock Holding History

Alpha Paradigm Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-412
Closed -$199K – 512
2022
Q2 		$199K Sell
412
-91
-18% -$45K 0.08% 321
2022
Q1 		$247K Sell
503
-277
-36% -$127K 0.1% 307
2021
Q4 		$362K Sell
780
-457
-37% -$192K 0.15% 238
2021
Q3 		$461K Sell
1,237
-45
-4% -$17.1K 0.18% 190
2021
Q2 		$489K Buy
+1,282
New +$490K 0.18% 188

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Alpha Paradigm Partners's ELV Position: Q3 2022 in Review

Alpha Paradigm Partners sold out of Elevance Health (ELV) in Q3 2022, closing a stake of 412 shares — an estimated $199K sold.

Alpha Paradigm Partners first reported a position in ELV in Q2 2021 and held it in 5 quarters. The position peaked at $489K in Q2 2021. 1,445 funds tracked by Wall St. Rank hold ELV as of Q3 2022.

  • Alpha Paradigm Partners reported no remaining Elevance Health position as of Q3 2022 after selling out during the quarter.
  • Alpha Paradigm Partners sold 412 Elevance Health shares in Q3 2022, an estimated $199K.
  • Alpha Paradigm Partners first reported a position in Elevance Health in Q2 2021 and held it in 5 quarters.
  • Alpha Paradigm Partners's Elevance Health position peaked at $489K in Q2 2021.
  • 1,445 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.

Based on Alpha Paradigm Partners's 13F filing for Q3 2022, filed 15 Nov 2022.